-
-
-
-
-
-
-
Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application
-
-
-
-
-
-
-
Theratechnologies Reports Second Quarter and First Half Fiscal 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Theratechnologies Presents Results From Trogarzo® IV Push Administration Study at CROI 2022
15,422 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

